Fig. 4From: Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancerDifferences in ssGSEA scores in response to DNA damage stimulation between different radiotherapy times in two prostate cancer cell typesBack to article page